| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $102.3M | — | +17.4% |
| Cost of Revenue | $34.0M | — | +18.9% |
| Gross Profit | $68.2M | — | +16.6% |
| R&D Expense | $19.8M | — | +57.5% |
| SG&A Expense | $74.6M | — | +47.9% |
| Operating Income | -$57.5M | — | -1162.8% |
| Pre-tax Income | -$62.4M | — | -926.3% |
| Income Tax | $897K | — | +100.7% |
| Net Income | -$63.3M | — | -869.8% |
| EPS (Basic) | -$2.16 | — | -839.1% |
| EPS (Diluted) | -$2.16 | — | -839.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $93.9M | -10.5% | -5.8% |
| Short-term Investments | $76.8M | +15.8% | +29.1% |
| Accounts Receivable | $76.9M | +3.4% | +67.3% |
| Inventory | $12.2M | -12.3% | -3.3% |
| Current Assets | $270.6M | +0.9% | +19.8% |
| Total Assets | $506.3M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$32.4M | — | -418.3% |
| Capital Expenditures | $6.5M | — | +5.3% |
| Investing Cash Flow | -$17.3M | — | -83.4% |
| Financing Cash Flow | $38.6M | — | +181.3% |
| Free Cash Flow | -$38.9M | — | -1058.8% |
| +13.4% |
| Current Liabilities | $87.6M | -19.5% | +26.0% |
| Long-term Debt | $100.0M | +83.3% | +80.3% |
| Total Liabilities | $252.2M | +17.0% | +33.4% |
| Stockholders' Equity | $254.1M | -17.5% | -1.3% |